Impact of Socio-aesthetic Care in the Quality of Life of Patients Treated for Lymphoma During and After Hospitalization (CareSSE)
|ClinicalTrials.gov Identifier: NCT02072655|
Recruitment Status : Completed
First Posted : February 26, 2014
Last Update Posted : June 16, 2016
In the early 2000s , professional and patient organizations are mobilizing to highlight the psychosocial impact of cancer disease , not only during but also after the acute phase.
In 2003, the government launched the Cancer Plan I reinforced in December 2011 by the Cancer Plan II whose objectives include : " Develop a personalized care taking into account the pain and psychological and social support " and " increase opportunities for patients to benefit from supportive care "and" promote the professional integration .
This study aims to show that beyond the immediate benefits of the social aesthetic cares in hospital (direct soothing, improving the quality of the skin injured by chemotherapy , feeling of escape ... ), these treatments can also affect quality of life for patients during and after hospitalization. They also may have an impact on the maintenance of social and / or professional satisfactory throughout the planned chemotherapy aplastic period .
|Condition or disease||Intervention/treatment||Phase|
|Lymphoma||Procedure: socio-aesthetic care||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||40 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Primary Purpose:||Supportive Care|
|Official Title:||Impact of Socio-aesthetic Care in the Quality of Life of Patients Treated for Lymphoma During and After Hospitalization|
|Study Start Date :||January 2014|
|Actual Primary Completion Date :||January 2016|
|Actual Study Completion Date :||January 2016|
|No Intervention: without socio-asthetic care|
|Experimental: with socio-aesthetic cares||
Procedure: socio-aesthetic care
- Quality of life score [ Time Frame: Change form baseline in Quality of life score at an average of 5 months (4 to 6 cycles of chemotherapy). ]
- For patients in control group, arbitrarily during their fifth cycle of chemotherapy
- For patients in interventional group during the course of chemotherapy after the third socio-aesthetic care, or at the latest, at the sixth treatment.
- Coopersmith Self-esteem inventory [ Time Frame: Change form baseline in Coopersmith Self-esteem inventory score at an average of 5 months (4 to 6 cycles of chemotherapy). ]
- Body Image Scale assessment [ Time Frame: Change form baseline in body image scale assessment score at an average of 5 months (4 to 6 cycles of chemotherapy). ]
- Social life assessment [ Time Frame: Change form baseline in social life assessment score at an average of 5 months (4 to 6 cycles of chemotherapy). ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02072655
|Hematology Care Unit - UH Angers|
|Angers, France, 49000|